Results 141 to 150 of about 7,691 (193)

Feline Lymphoma in Focus: Examining the Patterns and Types in Croatia's Pathological Records. [PDF]

open access: yesVet Sci
Eraghi V   +12 more
europepmc   +1 more source

Sporotrichosis incidence and risk factors in cats in Thonburi District, Bangkok, Thailand: A retrospective study. [PDF]

open access: yesOpen Vet J
Kulnides N   +7 more
europepmc   +1 more source

Formation and Characterization of FeLV ISCOMs [PDF]

open access: yesVaccine, 1989
Immunostimulating complexes (ISCOMs) have been prepared from feline leukaemia virus (FeLV) envelope proteins. The ISCOMs were characterized biochemically in SDS-polyacrylamide gel electrophoresis showing the presence of proteins of estimated molecular weights of 15,000, 27,000 and 70,000.
Bror Morein, S Höglund, L Åkerblom
exaly   +6 more sources

Serological Responses in Cats Vaccinated With FeLV ISCOM and an Inactivated FeLV Vaccine

Vaccine, 1989
Various approaches have been considered for generation of effective and safe vaccines against retroviruses, including HIV, with limited success. In the present vaccination study, encompassing 137 household cats, we have composed an experimental ISCOM subunit vaccine containing gp70 of feline leukaemia virus (FeLV)--the external glycosylated envelope ...
Bror Morein, L Åkerblom, K Weijer
exaly   +5 more sources

Suppression of in Vitro Neutrophil Function by Feline Leukaemia Virus (FeLV) and Purified FeLV-p15E

open access: yesJournal of General Virology, 1987
Feline neutrophils (PMN) were isolated and exposed to ultraviolet light-inactivated feline leukaemia virus (UV-FeLV) and purified envelope component p15E (FeLV-p15E). Functional capacity of exposed PMN was measured in vitro utilizing the chemiluminescence (CL) response. PMN exposed to UV-FeLV demonstrated depressed CL responses to Ca2+-ionophore A23187
Mark G Lewis, R G Olsen, Louis J Lafrado
exaly   +3 more sources

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity [PDF]

open access: yesInternational Journal of Molecular Sciences, 2023
Feline leukemia virus (FeLV) is one of the most prevalent infectious diseases in domestic cats. Although different commercial vaccines are available, none of them provides full protection. Thus, efforts to design a more efficient vaccine are needed.
Julià Blanco   +2 more
exaly   +2 more sources

Efficacy of an Inactivated FeLV Vaccine Compared to a Recombinant FeLV Vaccine in Minimum Age Cats Following Virulent FeLV Challenge

Vaccine, 2014
The aim of the study was to determine the efficacy of an inactivated feline leukemia virus (FeLV) vaccine (Versifel(®) FeLV, Zoetis.) compared to a recombinant FeLV vaccine (Purevax(®) FeLV, Merial Animal Health) in young cats, exposed under laboratory conditions to a highly virulent challenge model.
Kristin, Stuke   +5 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy